Home › Oropharyngeal Cancer

Oropharyngeal Cancer clinical trials recruiting in the U.S.

52 studies for Oropharyngeal Cancer are recruiting participants at sites across the United States.

Cities with the most studies

• Edison, NJ8 studies
• Atlanta, GA8 studies
• Chicago, IL7 studies
• New York City, NY6 studies
• Queens, NY5 studies
• Milwaukee, WI5 studies
• St. Louis, MO5 studies
• Kansas City, MO5 studies
• Omaha, NE5 studies
• Los Angeles, CA5 studies
• Philadelphia, PA5 studies
• Pittsburgh, PA5 studies
• Houston, TX5 studies
• Tampa, FL5 studies
• Rochester, MN4 studies
• Greenburgh, NY4 studies
• Staten Island, NY4 studies
• East Norwalk, CT4 studies
• Durham, NC4 studies
• Overland Park, KS4 studies
• Kansas City, KS4 studies
• Detroit, MI4 studies
• Ann Arbor, MI4 studies
• Naperville, IL4 studies
• Washington, DC4 studies
• Richmond, VA4 studies
• Baltimore, MD4 studies
• New Rochelle, NY3 studies
• Des Moines, IA3 studies
• Danville, IL3 studies
• Oklahoma City, OK3 studies
• Portland, OR3 studies
• Charleston, IL3 studies
• Champaign, IL3 studies
• West Bend, WI3 studies
• Fargo, ND3 studies
• Joliet, IL3 studies
• Wausau, WI3 studies
• Peoria, IL3 studies
• North Peoria, IL3 studies

By state

• Arizona4 studies
• California9 studies
• Colorado4 studies
• District of Columbia3 studies
• Florida12 studies
• Georgia8 studies
• Illinois8 studies
• Iowa5 studies
• Kansas5 studies
• Kentucky3 studies
• Maryland7 studies
• Massachusetts4 studies
• Michigan6 studies
• Minnesota6 studies
• Missouri9 studies
• Nebraska5 studies
• New Hampshire3 studies
• New Jersey8 studies
• New York11 studies
• North Carolina6 studies
• North Dakota3 studies
• Ohio8 studies
• Oklahoma4 studies
• Oregon3 studies
• Pennsylvania10 studies
• South Carolina3 studies
• Tennessee3 studies
• Texas6 studies
• Vermont3 studies
• Virginia4 studies
• Wisconsin6 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.